Blog Archives

Hot Topics: Trends in kinase drug discovery: twenty years of successfully targeting the kinome

The FDA approval of imatinib in 2001 was a breakthrough in molecularly targeted cancer therapy and heralded the emergence of kinase inhibitors as a key drug class in the oncology area and beyond. Continued advances in the molecular understanding of

Tagged with: , ,
Posted in Hot Topics